Xingzhong Hu
- Infectious Diseases top 5%
- Neurology top 10%
- Epidemiology
- Oncology
- Molecular Biology
- Topics
- COVID-19 Clinical Research Studies (6 papers)SARS-CoV-2 and COVID-19 Research (2 papers)Respiratory viral infections research (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xingzhong Hu
14 papers receiving 510 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 388
- Neurology 134
- Epidemiology 133
- Oncology 112
- Molecular Biology 73
Countries citing papers authored by Xingzhong Hu
This map shows the geographic impact of Xingzhong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingzhong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingzhong Hu more than expected).
Fields of papers citing papers by Xingzhong Hu
This network shows the impact of papers produced by Xingzhong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingzhong Hu. The network helps show where Xingzhong Hu may publish in the future.
Co-authorship network of co-authors of Xingzhong Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Xingzhong Hu. A scholar is included among the top collaborators of Xingzhong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingzhong Hu. Xingzhong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 45 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 236 | |
| 9 | 123 | |
| 10 | 66 | |
| 11 | 2 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | 4 | |
| 15 | RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a meta-analysis. | 7 |
About Xingzhong Hu
Xingzhong Hu is a scholar working on Infectious Diseases, Virology and Critical Care and Intensive Care Medicine, having authored 15 papers that have together received 522 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Infectious Diseases (388 citations), Neurology (134 citations) and Obstetrics and Gynecology (44 citations). Xingzhong Hu has collaborated with scholars based in China and United States. Frequent co-authors include Guiqing He, Wei Ye, Lianpeng Wu, Suyu Sun, Yong Pan, Yin Lin, Chaoyue Chen, Xuejiao Cai, Dong Chen and Dong Chen. Their work appears in journals such as Medicine, Clinica Chimica Acta and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.